Driving bioscience innovation, commercialization and talent development in Indiana

From innovation to impact, the IU LAB is driving breakthrough life science discoveries into real world applications.

With a world-class facility set to open in Fall 2027, backed by the transformative $138 million Lilly Endowment grant, IU LAB is not waiting to seize the moment and is actively pushing the boundaries on what is possible as the front door to Indiana University’s life science ecosystem.

Between pioneering the model behind IU’s All-Services Master Agreements with industry leaders, nurturing a global cohort of biotech innovators, and catalyzing talent development focused on addressing pressing health challenges, IU LAB is fast-tracking the discoveries that will define the next generation of life science.

The power of research at Indiana University

Over $1 billion in research expenditures, FY25

$99 billion value of Indiana’s growing life science economy

$250 million commitment to advance life science discoveries and innovation

David Rosenberg

IU LAB represents an enormous opportunity to distinguish Indiana and the greater Indianapolis region as an international leader for biosciences research and innovation.

David Rosenberg, President and CEO of IU LAB

Five MOU Partners

  • Indiana Biosciences Research Institute
  • Regenstrief Institute
  • IU Health
  • 16 Tech
  • Central Indiana Corporate Partnership (CICP)

IU Partners

  • Convergent Bioscience & Technology Institute (CBATI)
  • Institute for Human Health & Wellbeing (IH2W)
  • Integrated Nanosystems Development Institute (INDI)
  • IU School of Medicine
  • IU Bloomington
  • Luddy School of Informatics, Computing, and Engineering
  • Kelley School of Business, IU Indianapolis
  • IU Indianapolis School of Science
  • Fairbanks School of Public Health